Nexentis Technologies Inc
n2off.comWhat Do They Do?
Develops cancer and inflammatory-disease drug candidates, and solar projects that it sells to third parties.
10-K for FY2025, filed Mar 31, 2026
How Do They Make Money?
$210K
-
10-K for FY2024, filed Mar 31, 2025
$210K ↗
Who Are Their Customers?
Solterra sells renewable energy projects to third parties at various stages of development.
10-K for FY2025, filed Mar 31, 2026Solterra Renewable Energy Ltd. – Solterra Renewable Energy Ltd., an Israeli corporation (“Solterra”), operates in the solar energy sector…View ↗
Do Revenues Turn Into Profits?
No. It lost $5.2M in FY2024.
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 13, 2026
−$11.1MView ↗
- ▲ +147% (Loss)
- vs −$4.5M in Q2 FY2025
-
Sep 3, 2026
Nasdaq cited an equity shortfall under its continued-listing rules
The company plans to submit a compliance plan; Nasdaq's notice did not immediately affect its listing.
Sources
8-K, filed Sep 3, 2026
On August 31, 2026, Nexentis Technologies Inc. (the “Company”) received a letter (“Letter”) from the Listing Qualifications Staff (the…View ↗
-
Aug 6, 2026
The company replaced its independent auditor
The board dismissed KPMG Israel and appointed Deloitte Israel to audit the 2026 financial statements.
Sources
8-K, filed Aug 6, 2026
On August 6, 2026, the board of directors (the “Board”) and audit committee of the Board (the “Audit Committee”) of Nexentis Technologies…View ↗
Shrinking. Revenue fell 10% in 4 years, from $232.3K in FY2020 to $210K in FY2024, about 2% a year.
Oncology drug discovery
The older report centers on treatments for fresh produce; the latest describes MitoCareX developing cancer therapeutics through drug discovery.
10-K for FY2022, filed Mar 27, 2023 10-K for FY2025, filed Mar 31, 2026We are an agri-food tech company specializing in eco crop protection that helps reduce food waste and ensure food safety while reducing the…View ↗
MitoCareX Bio Ltd. – MitoCareX is a drug discovery company dedicated to the development of therapeutics related to cancer and inflammatory…View ↗
Solar project development
The latest report also describes Solterra developing solar projects for sale to third parties, alongside the earlier focus on food-industry treatments.
10-K for FY2022, filed Mar 27, 2023 10-K for FY2025, filed Mar 31, 2026We are an agri-food tech company specializing in eco crop protection that helps reduce food waste and ensure food safety while reducing the…View ↗
Solterra Renewable Energy Ltd. – Solterra Renewable Energy Ltd., an Israeli corporation (“Solterra”), operates in the solar energy sector…View ↗
Who Do They Compete With?
Competes with Relay Therapeutics, Daiichi Sankyo, and Scorpion Therapeutics
10-K for FY2025, filed Mar 31, 2026Company Link to Website Name of potential Competitive Product Description of the Product Relay Therapeutics, INC https://relaytx.com/…View ↗
Loading...
